Schedule 13G ownership disclosure
Coherus Oncology Inc
Common Stock, $0.0001 par value · CUSIP: 19249H103
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubric Capital Management LP
Shares: 5,258,754.00 · Class: 4.56%
- David Rosen
Shares: 5,258,754.00 · Class: 4.56%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-012904
- Form type
- SCHEDULE 13G/A
- Filer
- Coherus Oncology, Inc.
- CIK
- CIK 1512762
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership